Related Experiment Videos
HLA-B*8202 identified in a Caucasoid potential bone marrow donor
S T Cox1, E Hossain, A McWhinnie
1Anthony Nolan Research Institute, The Royal Free Hospital, London, United Kingdom.
Tissue Antigens
|October 6, 2000
Summary
Researchers discovered a new Human Leukocyte Antigen (HLA) B-locus allele, B*8202, differing by one nucleotide from B*8201. This finding highlights the importance of sequence-based typing for identifying novel HLA alleles and understanding genetic diversity.
Area of Science:
- Immunogenetics
- Molecular biology
- Human Leukocyte Antigen (HLA) system
Background:
- HLA class I alleles exhibit extensive polymorphism, particularly at the B-locus.
- Genetic diversity arises from mechanisms like point mutation, interallelic, and intergenic recombination.
Purpose of the Study:
- To describe a newly identified Human Leukocyte Antigen (HLA) B-locus allele, designated B*8202.
- To characterize the structural and evolutionary relationship of B*8202 to known alleles.
Main Methods:
- High-resolution sequence-based typing of HLA alleles.
- Comparative nucleotide and amino acid sequence analysis.
Main Results:
- A novel HLA B-locus allele, B*8202, was identified with a single nucleotide difference in exon 3 compared to B*8201, resulting in an amino acid substitution (aspartic acid to glycine).
- The identified amino acid in B*8202 (glycine) is consensus for B-locus alleles, suggesting B*8202 may be evolutionarily older than B*8201.
- Evidence suggests B*8201 is a hybrid allele, potentially formed through recombination events involving B*4501 and B*5602.
Conclusions:
- The discovery of B*8202 underscores the limitations of routine typing methods in detecting novel HLA variants.
- Sequence-based typing is crucial for accurate identification of HLA polymorphism and understanding allele evolution.
- Recombination events play a significant role in generating HLA diversity and explaining observed serological patterns.